Pakistan’s pharmaceutical exports surged to a 20-year high of $457 million in the last fiscal year, driven by the government’s pro-industry policies, marking a 34% year-on-year growth.

Industry leaders credited the government’s deregulation policy announced last year, which helped ease medicine shortages and boosted confidence among manufacturers.

“Over the past 12 months, we have seen remarkable improvements — a fresh breeze for the pharma industry,” said Tariq H. Taqi, Chairman of the Pharmaceutical Manufacturers Association.

He added that if the government sustains its business-friendly approach and continues supporting the private sector, pharma exports could reach $3-4 billion in the coming years.

Analysts say the latest export figures reflect the sector’s untapped potential, provided policy continuity remains in place.